FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis

Press/Media

Period	7 Nov 2024

Media coverage

Title	FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis
Media name/outlet	Hospitals-Management.com
Country/Territory	United States
Date	7/11/24
URL	ct.moreover.com/?a=55222258149&p=1gw&v=1&x=syRI9EqebX0zZqSCqG8USA
Persons	Kevin Chung